Emerging MRI-based approaches for in-vivo cell tracking of cellular therapeutics and inflammation

Le LabEx PRIMES (http://primes.universite-lyon.fr/) a le plaisir de vous inviter à la conférence :

Emerging MRI-based approaches for in-vivo cell tracking of cellular therapeutics and inflammation

ahrens_color.jpg

 Pr Eric T Ahrens

 Université de Californie, San Diego (UCSD, USA)

le vendredi 30 janvier 2015

de 12h30 à 13h30

sandwichs offerts, merci de vous inscrire en cliquant sur  "Inscription" dans le menu à gauche

à l'amphithéâtre de l'Institut Multidisciplinaire de Biochimie des Lipides (IMBL)

 11 rue Jean Capelle, INSA de Lyon, Villeurbanne

Résumé :

Eric T Ahrens is a Professor of biological science recently appointed at UCSD stem cell program. His research focuses on adapting magnetic resonance imaging (MRI) to visualize cellular and molecular processes in-vivo. He has developed first-generation MRI reporters by using transgenic and vector technologies to express reporter genes coding for novel iron-binding proteins in the ferritin family. In a second parallel track, he has developed a new field of cell tracking called ‘in vivo cytometry.' Cells are initially labeled in culture using novel perfluorocarbon (PFC) nanoemulsions. Following transfer to the subject, cells are tracked in vivo using fluorine-19 (19F) MRI. To push the field of cellular-molecular MRI forward, his lab takes an integrated approach that applies principles of chemistry, biology, medicine, nuclear spin physics, and image processing.

Plan :

plan_redimensionné

Personnes connectées : 1